Sarepta Therapeutics Inc (SRPT)
18.97
+0.69%
Sarepta Therapeutics Inc (SRPT) is currently trading at $18.97. This represents a gain of 0.69% from the previous session. With a market capitalization of $1.99B, SRPT is a key component of the Health Care sector. Investors looking to trade SRPT should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade SRPT commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Sarepta Therapeutics Inc (SRPT) shows a bullish trend. Analysts are watching the 19.25 level closely.
Fundamentals
Mkt Cap1.99B
P/E Ratio0.0000
Volume2,235,296
60-Day Technical Chart
Advanced Charting
Need more indicators for SRPT? Use the world's #1 platform.
Open SRPT on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $19
| Metric |
SRPT +0.69% |
SOFI +3.38% |
HPQ +0.05% |
KVUE -1.37% |
|---|---|---|---|---|
| Price | $18.97 | $19.29 | $18.21 | $18.77 |
| Mkt Cap | $1.99B | $24.60B | $16.72B | $35.98B |
| - | View → | View → | View → |
Latest Headlines
Inside Sarepta’s tumultuous $2.2B year in Duchenne gene therapy
Stock Titan • Feb 25, 2026
SRPT Stock Snaps Hot Winning Streak Ahead Of Q4 Print — What Bear Positioning And Big Money Are Signaling
Stocktwits • Feb 24, 2026
Sarepta Saga Has ‘Gone on Too Long’ as Competitors Catch Up
BioSpace • Feb 5, 2026
Is Sarepta Therapeutics (SRPT) Pricing Reflect A 82% Share Price Slump And DCF Upside?
Yahoo Finance • Jan 31, 2026
Japan's first Duchenne gene therapy offers option for kids 3-7
Stock Titan • Feb 24, 2026
● Gemini Agentic AI Analyst Insight for SRPT
Market Education
- Government Shutdowns: What They Mean for Wall Street Sep 26, 2025
- Money Cycle - Read once so simple Jun 6, 2021
- Trump’s New Tariffs Could Push Up Kitchen Renovation Costs Sep 26, 2025
External Research